Atmus Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 339.47%
- Profit Growth 774.03%
- Ebitda 778.23%
- Net Worth 193.95%
- Total Assets 31.23%
About Atmus Pharma
Atmus Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 January 2022 (Three years and one month 12 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Machara Chittala and Venkata Chittala serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304TG2022PTC158653
- Company No.
158653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2022
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Atmus Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Machara Chittala  | Director | 10-Jan-2022 | Current |
| Venkata Chittala | Director | 10-Jan-2022 | Current |
Financial Performance of Atmus Pharma.
Atmus Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 339.47% increase. The company also saw a substantial improvement in profitability, with a 774.03% increase in profit. The company's net worth Soared by an impressive increase of 193.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atmus Pharma?
Unlock access to Atmus Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Monvi Laboratories Private LimitedMachara Chittala is a mutual person
Cenote Healthcare Private LimitedMachara Chittala and Venkata Chittala are mutual person
- Jasvik Homes Private Limited
Machara Chittala is a mutual person
- Vertical Riser Projects Llp
Venkata Chittala is a mutual person
- Jsl Health Sciences Private Limited
Venkata Chittala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atmus Pharma?
Atmus Pharma has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atmus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atmus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.